Key fob
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view, as viewed from the left front, of a key fob showing my new design;
FIG. 2 is a right side elevational view, the left side elevational view being a mirror image thereof;
FIG. 3 is a rear elevational view thereof;
FIG. 4 is a top plan view thereof;
FIG. 5 is a bottom plan view thereof; and,
FIG. 6 is a perspective view thereof as viewed from the left rear.
Referenced Cited
Patent History
Patent number: D344183
Type: Grant
Filed: Oct 29, 1991
Date of Patent: Feb 15, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventor: Gregor J. M. Anderson (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: R. Seifert
Law Firm: Darby & Darby
Application Number: 7/784,816
Type: Grant
Filed: Oct 29, 1991
Date of Patent: Feb 15, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventor: Gregor J. M. Anderson (Ware)
Primary Examiner: A. Hugo Word
Assistant Examiner: R. Seifert
Law Firm: Darby & Darby
Application Number: 7/784,816
Classifications
Current U.S. Class:
D/3207